Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -29.22% | 2.44% | -93.35% | 74.72% | 12.18% |
| Total Depreciation and Amortization | 1.08% | 0.00% | -1.06% | 1.08% | -3.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.96% | 121.43% | 20.00% | -83.25% | -60.19% |
| Change in Net Operating Assets | -66.67% | 34.04% | 138.37% | -173.13% | 612.77% |
| Cash from Operations | -83.47% | 21.32% | 1.68% | 39.70% | 17.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.33% | 29.41% | 37.04% | -575.00% | 99.90% |
| Cash from Investing | 83.33% | 29.41% | 37.04% | -575.00% | 99.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -933.33% | 133.33% | -50.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | 15.79% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 160.98% | -1,466.67% | 107.32% | 6.82% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.98% | 12.63% | 11.38% | 35.04% | 83.18% |